Martin A. Ott - Concepedia

Author

Martin A. Ott

Eli Lilly (United States)ORCID

Also Known As

M. A. OTT, M. Ott, Martin A Ott, Martin A. Ott, Martin Ott

Publications

429

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Pfizer (United States)Galapagos (Belgium)Takeda (United States)Vertex Pharmaceuticals (United States)

About

Martin A. Ott is an author at Eli Lilly (United States) specializing in organic chemistry, engineering, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	150
2	Natural Sciences	3	3	179
3	Biochemistry	3	3	179
4	Medicine	2	2	166
5	Biomolecular Engineering	1	1	12

Martin A. Ott

Publications

351

Citations

H-Index

Page 1

	Year	Citations
Pathways for <i>N</i>-Nitroso Compound Formation: Secondary Amines and Beyond Rocío López‐Rodríguez, James A. McManus, Natasha S. Murphy, Organic Process Research & Development Drug SafetyMedicinal ChemistryPharmaceutical ScienceBiochemistryMedicine	2020	114
An Expert System To Predict the Forced Degradation of Organic Molecules Alexis D. C. Parenty, William G. Button, Martin A. Ott Molecular Pharmaceutics EngineeringChemical AnalysisDegradation ReactionOrganic ChemistryChemistry	2013	53
In Silico Prediction of Pharmaceutical Degradation Pathways: A Benchmarking Study Mark H. Kleinman, Steven W. Baertschi, Karen M. Alsante, Molecular Pharmaceutics EngineeringOrganic ChemistryKnowledge Base DevelopmentChemistryPharmaceutical Chemistry	2014	52
Correcting ligands, metabolites, and pathways Martin A. Ott, Gert Vriend BMC Bioinformatics	2006	50
A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies Chris Barber, Vincent Antonucci, Jens-Christoph Baumann, Regulatory Toxicology and Pharmacology Control MethodControl StrategyEngineeringCommand And ControlAutomation	2017	33
New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities Michael J. Burns, Martin A. Ott, Andrew Teasdale, Organic Process Research & Development	2019	23
<i>In Silico</i> Prediction of Pharmaceutical Degradation Pathways: A Benchmarking Study Using the Software Program Zeneth Rachel Hemingway, Steven W. Baertschi, David Benstead, Organic Process Research & Development	2024	14
Long-Range Strategies in the LHASA Program: The Quinone Diels−Alder Transform Martin A. Ott, J. H. Noordik Journal of Chemical Information and Computer Sciences Diversity Oriented SynthesisBioorganic ChemistryEngineeringBiochemistryLhasa Program	1997	12

Page 1